Sputnik V vaccine shows 92% efficacy, says Russia
Published
Russia's National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund on Wednesday announced that the Sputnik V vaccine, the world's first registered vaccine against coronavirus created on the well-studied platform of human adenoviral vectors, demonstrated 92 per cent efficacy.
Currently...